中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2014年
10期
152-153,154
,共3页
糖尿病%周围神经病变%硫辛酸%前列地尔
糖尿病%週圍神經病變%硫辛痠%前列地爾
당뇨병%주위신경병변%류신산%전렬지이
Diabetes%Peripheral neuropathy%Lipoic acid%Alprostadil
目的:分析糖尿病周围神经病变患者采用硫辛酸与前列地尔联合进行治疗的临床效果。方法:按照随机数字表法抽取本院2010-2012年收治的100例糖尿病周围神经病变患者,分成观察组与对照组,每组50例。对照组在常规治疗基础上采用前列地尔治疗,观察组在常规治疗上采用硫辛酸联合前列地尔进行治疗。比较两组的治疗结果。结果:观察组患者总有效为86%,对照组患者总有效率为60%,两组比较差异有统计学意义(P<0.05);治疗后观察组患者感觉神经传导速度(SNCV)、运动神经传导速度(MNCV)等改善情况较为明显,与对照组比较差异均有统计学意义(P<0.05)。结论:糖尿病周围神经病变患者采用硫辛酸与前列地尔联合进行临床治疗,临床效果确切,值得推广。
目的:分析糖尿病週圍神經病變患者採用硫辛痠與前列地爾聯閤進行治療的臨床效果。方法:按照隨機數字錶法抽取本院2010-2012年收治的100例糖尿病週圍神經病變患者,分成觀察組與對照組,每組50例。對照組在常規治療基礎上採用前列地爾治療,觀察組在常規治療上採用硫辛痠聯閤前列地爾進行治療。比較兩組的治療結果。結果:觀察組患者總有效為86%,對照組患者總有效率為60%,兩組比較差異有統計學意義(P<0.05);治療後觀察組患者感覺神經傳導速度(SNCV)、運動神經傳導速度(MNCV)等改善情況較為明顯,與對照組比較差異均有統計學意義(P<0.05)。結論:糖尿病週圍神經病變患者採用硫辛痠與前列地爾聯閤進行臨床治療,臨床效果確切,值得推廣。
목적:분석당뇨병주위신경병변환자채용류신산여전렬지이연합진행치료적림상효과。방법:안조수궤수자표법추취본원2010-2012년수치적100례당뇨병주위신경병변환자,분성관찰조여대조조,매조50례。대조조재상규치료기출상채용전렬지이치료,관찰조재상규치료상채용류신산연합전렬지이진행치료。비교량조적치료결과。결과:관찰조환자총유효위86%,대조조환자총유효솔위60%,량조비교차이유통계학의의(P<0.05);치료후관찰조환자감각신경전도속도(SNCV)、운동신경전도속도(MNCV)등개선정황교위명현,여대조조비교차이균유통계학의의(P<0.05)。결론:당뇨병주위신경병변환자채용류신산여전렬지이연합진행림상치료,림상효과학절,치득추엄。
Objective:To explore the clinical effect of alprostadil combined with lipoic acid in treatment of diabetic peripheral neuropathy. Method:One hundred patients of diabetic peripheral neuropathy disease in the hospital from 2010 to 2012 were randomly divided into the control group and the observation group,each group of 50 cases. The control group was treated by alprostadil based on the conventional treatment. The observation group was treated by alprostadil combined with lipoic acid based on the conventional treatment. The clinical effect between the two groups was compared after treatment. Result:The effective rate of the control group was 60%while the treatment group was 86%after treatment,and the difference between the two groups were statistically significant(P<0.05).The observation group of patients with sensory nerve conduction velocity(SNCV)and motor nerve conduction velocity(MNCV)compared with control group after treatment, and the difference between the two groups were all statistically significant(P<0.05). Conclusion:The clinical effect of alprostadil combined with lipoic acid in treatment of diabetic peripheral neuropathy is excellent. It is worth popularization and application.